A prospective cohort study of 54 uveitis patients found comparable six-month treatment success rates regardless of baseline ...
Recent use of intravenous bisphosphonates is associated with a higher short-term risk for uveitis, while oral forms show no clear association, a study finds.
A retrospective study of 49 patients found that multiple sclerosis disease-modifying therapies were linked to fewer uveitis ...
Until recently, fluorescein FA was the primary imaging modality used to detect macular edema and other features related with uveitis like choroidal neovascularization and serous retinal detachment.
New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help ...
Please provide your email address to receive an email when new articles are posted on . Uveitis describes inflammation that exists in the uveal tract, but the disease course has such a variety of ...
A professor and the chairman of the Department of Ophthalmology at Mount Sinai, Jabs has specialized in treating uveitis for 25 years. Who’s at risk Uveitis is an inflammatory process that affects the ...
Early diagnosis and treatment with biologic drugs, such as Enbrel, can control swelling Joy Ross says it was love at first touch. Ross, who is now blind, likes to tease that she met her husband, ...
People with a history of uveitis were more likely to experience recurrences of the potentially dangerous eye inflammation after vaccination against COVID-19, a retrospective population-based cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results